Preview Mode Links will not work in preview mode

This Week in Cardiology

Aug 12, 2022

AF screening; sodium, potassium, BP, and CV outcomes; drug prices; and cardio-respiratory fitness are the topics John Mandrola, MD, covers in this week’s podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I. AF Screening

- Using Wearable Devices to Detect AF Is 'Cost Effective'

- Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices

- Screening for Atrial Fibrillation in Asymptomatic Older Adults

II. Salt Substitutes

- More Evidence Salt Substitutes Lower Risk of CVD and Death

- Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis

- Effect of Salt Substitution on Cardiovascular Events and Death

- Settling the controversy of salt substitutes and stroke: sodium reduction or potassium increase?

- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

- Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

III. Drug Prices

- House Could Soon Give Biden Win on Medicare Drug Negotiations, Insulin Costs

IV. Fitness is Under-rated

- Cardiorespiratory Fitness Key to Longevity for All?

- Cardiorespiratory Fitness and Mortality Risk Across the Spectra of Age, Race, and Sex

- Cardiorespiratory fitness, obesity and left atrial function in patients with atrial fibrillation

You also may like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact